Scarica l'app Stockscreener
14.97
3.04%
-0.47
Dopo l'orario di chiusura:
14.97
Precedente Chiudi:
$15.44
Aprire:
$15.45
Volume 24 ore:
89,619
Relative Volume:
0.42
Capitalizzazione di mercato:
$560.64M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-1.96%
1M Prestazione:
+4.69%
6M Prestazione:
+47.63%
1 anno Prestazione:
-46.52%
Intervallo 1D:
$14.70
$15.45
Intervallo di 1 settimana:
$14.61
$16.12
Portata 52W:
$5.485
$31.13
Oruka Therapeutics Inc Stock (ORKA) Company Profile
Nome
Oruka Therapeutics Inc
Settore
Industria
Telefono
650-606-7910
Indirizzo
855 OAK GROVE AVE., MENLO PARK
Confronta ORKA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ORKA
Oruka Therapeutics Inc
|
14.97 | 582.73M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Oruka Therapeutics Inc Stock (ORKA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-22 | Iniziato | BTIG Research | Buy |
| 2025-02-04 | Iniziato | Wolfe Research | Outperform |
| 2024-10-11 | Iniziato | Stifel | Buy |
| 2024-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2024-09-17 | Iniziato | Leerink Partners | Outperform |
| 2024-09-16 | Iniziato | TD Cowen | Buy |
| 2024-09-13 | Iniziato | Jefferies | Buy |
| 2018-02-27 | Iniziato | Ascendiant Capital Markets | Buy |
| 2013-10-09 | Iniziato | Dawson James | Buy |
Mostra tutto
Oruka Therapeutics Inc Borsa (ORKA) Ultime notizie
Can Oruka Therapeutics Inc. expand into new marketsGap Up & Low Risk High Reward Ideas - khodrobank.com
Will a bounce in Oruka Therapeutics Inc. offer an exitWeekly Profit Summary & Daily Volume Surge Trade Alerts - Newser
Using data filters to optimize entry into Oruka Therapeutics Inc.Weekly Trend Summary & Technical Entry and Exit Alerts - Newser
Short interest data insights for Oruka Therapeutics Inc.Portfolio Risk Summary & Real-Time Market Trend Scan - Newser
Sector ETF performance correlation with Oruka Therapeutics Inc.July 2025 Closing Moves & Weekly Chart Analysis and Guides - Newser
Revenue Check: Can Oruka Therapeutics Inc. expand into new marketsMarket Rally & Stepwise Entry and Exit Trade Signals - khodrobank.com
Does Oruka Therapeutics Inc. fit your quant trading modelWeekly Investment Recap & High Accuracy Trade Signal Alerts - Newser
How to read the order book for Oruka Therapeutics Inc.Index Update & Low Drawdown Trading Techniques - Newser
How to monitor Oruka Therapeutics Inc. with trend dashboardsJuly 2025 Earnings & Reliable Momentum Entry Alerts - Newser
Oruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
Oruka Therapeutics Inc. stock chart pattern explainedMarket Performance Recap & Fast Exit and Entry Strategy Plans - Newser
Is this a good reentry point in Oruka Therapeutics Inc.Earnings Growth Summary & Real-Time Chart Breakout Alerts - Newser
Oruka Therapeutics Inc. recovery potential after sell offLayoff News & Risk Controlled Stock Pick Alerts - Newser
How high can Oruka Therapeutics Inc. stock goBond Market & Long Hold Capital Preservation Tips - Newser
Analyzing recovery setups for Oruka Therapeutics Inc. investorsInsider Buying & Reliable Breakout Forecasts - Newser
Is Oruka Therapeutics Inc. still worth holding after the dipEarnings Risk Summary & High Accuracy Trade Signal Alerts - Newser
Is Oruka Therapeutics Inc. part of any ETFJuly 2025 Action & High Accuracy Buy Signal Tips - khodrobank.com
What MACD signals say about Oruka Therapeutics Inc.July 2025 Gainers & Weekly High Conviction Trade Ideas - Newser
Is Oruka Therapeutics Inc. undervalued by DCF analysis2025 Dividend Review & Real-Time Chart Breakout Alerts - khodrobank.com
What are the future prospects of Oruka Therapeutics Inc.Weekly Earnings Recap & Capital Efficiency Focused Strategies - khodrobank.com
Does Oruka Therapeutics Inc. qualify in momentum factor screeningJuly 2025 Outlook & Stepwise Trade Signal Implementation - Newser
What data driven models say about Oruka Therapeutics Inc.’s futureTrend Reversal & Capital Protection Trade Alerts - Newser
How Oruka Therapeutics Inc. stock performs during market volatilityEarnings Beat & AI Forecasted Stock Moves - sundaytimes.kr
Evaluating Oruka Therapeutics Inc. with trendline analysisJuly 2025 EndofMonth & AI Powered Trade Plan Recommendations - Newser
What’s the profit margin of Oruka Therapeutics Inc.July 2025 Update & Free Risk Controlled Daily Trade Plans - sundaytimes.kr
Applying Elliott Wave Theory to Oruka Therapeutics Inc.2025 Market Outlook & Reliable Breakout Forecasts - Newser
Oruka Therapeutics Inc.’s volatility index tracking explainedWeekly Profit Summary & Daily Chart Pattern Signals - Newser
Applying Wyckoff theory to Oruka Therapeutics Inc. stockPortfolio Risk Report & AI Driven Price Predictions - Newser
Applying sector rotation models to Oruka Therapeutics Inc.July 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
Oruka Therapeutics Inc Azioni (ORKA) Dati Finanziari
Non sono disponibili dati finanziari per Oruka Therapeutics Inc (ORKA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Oruka Therapeutics Inc Azioni (ORKA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Venrock Healthcare Capital Par | 10% Owner |
Feb 13 '25 |
Buy |
11.63 |
14,950 |
173,868 |
4,059,634 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 12 '25 |
Buy |
11.86 |
8,971 |
106,396 |
4,044,684 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 11 '25 |
Buy |
10.95 |
9,593 |
105,043 |
4,035,713 |
| Venrock Healthcare Capital Par | 10% Owner |
Feb 10 '25 |
Buy |
10.90 |
574 |
6,257 |
4,026,120 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):